88 related articles for article (PubMed ID: 790952)
21. Variability in dobutamine pharmacokinetics in unstable critically ill surgical patients.
Klem C; Dasta JF; Reilley TE; Flancbaum LJ
Crit Care Med; 1994 Dec; 22(12):1926-32. PubMed ID: 7988128
[TBL] [Abstract][Full Text] [Related]
22. Analog-computer method for rapid estimates of theophylline clearance using presteady-state plasma concentrations.
Errick JK
Am J Hosp Pharm; 1982 May; 39(5):829-31. PubMed ID: 7081257
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetic and therapeutic monitoring in the development of theophylline-retard preparations].
Iwainsky H; Wilke A; Weide W; Schäfer K
Pharmazie; 1987 Apr; 42(4):242-4. PubMed ID: 3615555
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
[TBL] [Abstract][Full Text] [Related]
26. Intravenous theophylline therapy: nomogram guidelines.
Jusko WJ; Koup JR; Vance JW; Schentag JJ; Kuritzky P
Ann Intern Med; 1977 Apr; 86(4):400-4. PubMed ID: 848801
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic properties of a new sustained-release theophylline preparation.
Dahlqvist R; Billing B
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
[TBL] [Abstract][Full Text] [Related]
28. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
29. Saliva-serum theophylline concentrations: substantial intrapatient and interpatient variation in predicting serum concentrations.
Uden DL; Miller KW; Strand LM; Johnson PB; Zaske DE
Ther Drug Monit; 1981; 3(2):143-50. PubMed ID: 7268827
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of theophylline in hepatic disease.
Mangione A; Imhoff TE; Lee RV; Shum LY; Jusko WJ
Chest; 1978 May; 73(5):616-22. PubMed ID: 648214
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children.
Loughnan PM; Sitar DS; Ogilvie RI; Eisen A; Fox Z; Neims AH
J Pediatr; 1976 May; 88(5):874-9. PubMed ID: 1271155
[TBL] [Abstract][Full Text] [Related]
32. The influence of cigarette smoking and sex on theophylline disposition.
Powell JR; Thiercelin JF; Vozeh S; Sansom L; Riegelman S
Am Rev Respir Dis; 1977 Jul; 116(1):17-23. PubMed ID: 879596
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the "condition correction factor" method of estimating theophylline clearance.
Gotz VP; Russell WL; Lopez LM
Ther Drug Monit; 1983; 5(1):103-7. PubMed ID: 6845393
[TBL] [Abstract][Full Text] [Related]
34. The relationship between arterial blood gases and serum theophylline clearance in critically ill patients.
Westerfield BT; Carder AJ; Light RW
Am Rev Respir Dis; 1981 Jul; 124(1):17-20. PubMed ID: 7020503
[TBL] [Abstract][Full Text] [Related]
35. Theophylline disposition in obesity.
Gal P; Jusko WJ; Yurchak AM; Franklin BA
Clin Pharmacol Ther; 1978 Apr; 23(4):438-44. PubMed ID: 630791
[TBL] [Abstract][Full Text] [Related]
36. Algorithms for dosage and therapeutic monitoring of theophylline.
Mangues MA; Bonal J; Farré R; Francesc Massó J
Drug Intell Clin Pharm; 1988 Nov; 22(11):893-4. PubMed ID: 3234258
[TBL] [Abstract][Full Text] [Related]
37. Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit.
Dager WE; Albertson TE
Ann Pharmacother; 1992 Oct; 26(10):1287-91. PubMed ID: 1421656
[TBL] [Abstract][Full Text] [Related]
38. Effects of betamethasone on theophylline disposition in man. Are saliva values predictive of serum theophylline levels?
De Marino V; Pisanti N; Capone D; Annicelli A; Del Donno M; Marsico SA
Pharmacol Res Commun; 1986 Oct; 18(10):909-21. PubMed ID: 3809234
[TBL] [Abstract][Full Text] [Related]
39. Theophylline for chronic symptomatic bradycardia in the elderly.
Ling CA; Crouch MA
Ann Pharmacother; 1998; 32(7-8):837-9. PubMed ID: 9681101
[TBL] [Abstract][Full Text] [Related]
40. Dose-dependent theophylline elimination in an adult.
Creger RJ; Ball WD; Bahntge MF
Drug Intell Clin Pharm; 1983 Mar; 17(3):202-5. PubMed ID: 6839945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]